Bottom line
PPH vs MEDX: the short answer
PPH (VanEck Pharmaceutical ETF) and MEDX (Horizon Kinetics Medical ETF) share a meaningful slice of their top holdings — about 53% by weight.
PPH is cheaper at 0.36% vs 0.85% — a difference of $49 a year per $10,000 invested.
Over five years, PPH returned +11.3% a year vs +5.8% for MEDX.
Updated Nov 19, 2026
PPH vs MEDX side by side
| PPH | MEDX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | Roundhill |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.36% | 0.85% |
| Annual cost per $10k | $36 | $85 |
| 10-yr cost on $10k (prospectus) | $456 | $1,049 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.9% | +28.4% |
| 5-yr return (annualized) | +11.3% | +5.8% |
| 10-yr return (annualized) | +6.7% | +5.7% |
| Best quarter | +16.5% | +15.0% |
| Worst quarter | −15.0% | −12.9% |
| Net assets (fund) | $879.5M | $19.1M |
| Number of holdings | 26 | 33 |
| Portfolio turnover | 3% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PPH | MEDX | Difference |
|---|---|---|---|
| 2025 | +21.9% | +28.4% | −6.5% |
| 2024 | +8.1% | −4.7% | +12.9% |
| 2023 | +6.9% | −6.0% | +12.9% |
| 2022 | +2.6% | +4.2% | −1.6% |
| 2021 | +18.3% | +10.6% | +7.7% |
| 2020 | +5.2% | +9.0% | −3.8% |
| 2019 | +19.1% | +16.0% | +3.1% |
| 2018 | −5.7% | +1.7% | −7.3% |
| 2017 | +15.4% | +10.7% | +4.7% |
| 2016 | −17.8% | −8.0% | −9.8% |
Source: Fund prospectus bar charts
Holdings overlap
10 of PPH's top 25 holdings also appear in MEDX's top 25.
| Holding | PPH | MEDX |
|---|---|---|
| Eli Lilly & Co | 20.23% | 18.46% |
| Novartis AG | 10.63% | 6.89% |
| Merck & Co Inc | 9.85% | 3.96% |
| AbbVie Inc | 4.57% | 8.85% |
| Pfizer Inc | 4.51% | 2.86% |
| Bristol-Myers Squibb Co | 4.47% | 4.42% |
| Gsk Plc | 4.42% | 2.71% |
| Johnson & Johnson | 4.35% | 5.59% |
| AstraZeneca PLC | 4.33% | 4.98% |
| Haleon PLC | 3.09% | 0.60% |
Source: SEC Form N-PORT
PPH top 10
- Eli Lilly & Co — 20.23%
- Novartis AG — 10.63%
- Merck & Co Inc — 9.85%
- Novo Nordisk A/S — 5.37%
- AbbVie Inc — 4.57%
- Pfizer Inc — 4.51%
- Bristol-Myers Squibb Co — 4.47%
- Gsk Plc — 4.42%
- Johnson & Johnson — 4.35%
- AstraZeneca PLC — 4.33%
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
FAQ
What is the difference between PPH and MEDX?
Which is cheaper, PPH or MEDX?
Should I own both PPH and MEDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.